Prime Medicine, Inc.

Ownership Transactions Reported by 21 Insiders

Symbol
PRME on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
60 First St., Cambridge, MA

Insiders trading volume in the past year

Prime Medicine, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Gv 2019 Gp, L.L.C. 10%+ Owner $178M Jun 20, 2023
Fmr Llc Other* $127M Oct 24, 2022
Robert Nelsen Director, 10%+ Owner $73.9M +$10M +15.6% Aug 1, 2025
ARCH Venture Partners X, LLC 10%+ Owner $73.9M +$10M +15.7% Aug 1, 2025
ARCH Venture Partners XII, LLC 10%+ Owner $73.9M +$10M +15.7% Aug 1, 2025
David R. Liu 10%+ Owner $50.9M +$163K +0.32% Jun 30, 2025
Gv 2023 Gp, L.L.C. Member of 10% Group $20M Feb 20, 2024
Keith Michael Gottesdiener Exhibit 24 - Power of Attorney; Title: President and Chief Executive Officer, Director $19M May 8, 2025
Gv 2021 Gp, L.L.C. 10%+ Owner $10.8M +$4.95M +85.1% Aug 1, 2025
Allan Reine Chief Executive Officer, Director $147K +$147K Aug 1, 2025
Ann L. Lee Chief Technical Officer $113K +$113K Aug 1, 2025
Richard Brudnick Chief Business Officer $23.8K +$23.8K May 20, 2025
Thomas Cahill Director Aug 1, 2025
David P. Schenkein Director Aug 1, 2025
Jeffrey D. Marrazzo Director Aug 1, 2025
Michael Aaron Kelly Director Aug 1, 2025
Carman Alenson Exhibit 24 - Power of Attorney Aug 1, 2025
Kaye I. Foster-Cheek Director Aug 1, 2025
Wendy Chung Director Aug 1, 2025
Meredith Goldwasser SVP, Strategy & Corporate Ops. Feb 27, 2025
Jeremy Duffield Chief Scientific Officer Feb 27, 2025

Recent Insider Transactions by Companies or Individuals for Prime Medicine, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.